CalciMedica, Inc.
CALC
$4.50
-$0.19-4.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.95M | 9.37M | 9.18M | 9.73M | 8.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.91M | 25.03M | 24.93M | 24.20M | 22.35M |
| Operating Income | -24.91M | -25.03M | -24.93M | -24.20M | -22.35M |
| Income Before Tax | -23.06M | -20.87M | -18.87M | -13.70M | -13.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.06 | -20.87 | -18.87 | -13.70 | -13.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.06M | -20.87M | -18.87M | -13.70M | -13.59M |
| EBIT | -24.91M | -25.03M | -24.93M | -24.20M | -22.35M |
| EBITDA | -24.85M | -24.97M | -24.88M | -24.15M | -22.29M |
| EPS Basic | -1.60 | -1.59 | -1.55 | -1.18 | -1.57 |
| Normalized Basic EPS | -1.00 | -0.99 | -0.97 | -0.73 | -0.98 |
| EPS Diluted | -1.60 | -1.59 | -1.55 | -1.18 | -1.57 |
| Normalized Diluted EPS | -1.00 | -0.99 | -0.97 | -0.73 | -0.98 |
| Average Basic Shares Outstanding | 57.15M | 53.21M | 49.35M | 44.98M | 37.76M |
| Average Diluted Shares Outstanding | 57.15M | 53.21M | 49.35M | 45.27M | 38.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |